Reducing glucose uptake by BC cells through GLUT inhibition is a key approach, as is interfering with glycolysis by inhibiting the activity of glycolytic enzymes such as hexokinase and lactate dehydrogenase. This evidence concerns the gene SLC2A1 and breast cancer.